CN101204410B - External medicine for vitligo - Google Patents

External medicine for vitligo Download PDF

Info

Publication number
CN101204410B
CN101204410B CN2007103055576A CN200710305557A CN101204410B CN 101204410 B CN101204410 B CN 101204410B CN 2007103055576 A CN2007103055576 A CN 2007103055576A CN 200710305557 A CN200710305557 A CN 200710305557A CN 101204410 B CN101204410 B CN 101204410B
Authority
CN
China
Prior art keywords
medicine
effect
treatment
vitiligo
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007103055576A
Other languages
Chinese (zh)
Other versions
CN101204410A (en
Inventor
干慕美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007103055576A priority Critical patent/CN101204410B/en
Publication of CN101204410A publication Critical patent/CN101204410A/en
Application granted granted Critical
Publication of CN101204410B publication Critical patent/CN101204410B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese traditional medicine preparation which is a external coating medicine treating leuko derma.The medicine is made from the ingredient with the weight account:10g white caltrop flower and common aucklandia root for each, 15g sulfur and camphor for each, 30g leadoxide, 6g blister bedtle, 12g calomel and 1,000ml rice vinegar. The invention is characterized by novel prescription, low cost, convenient preparation and remarkable effect.

Description

The leukodermic medicine for external application of a kind of treatment
Technical field:
The present invention relates to a kind of Chinese medicine preparation, promptly treat the very good leukodermic medicine for external application of a kind of treatment of vitiligo effect.
Background technology:
Vitiligo is that a kind of limitation skin pigment posteriority takes off the mistake disease, and its symptom shows as: symmetry, the pigment decolouring speckle that differs in size are white in color clear border, no conscious sympton etc.At present, treating leukodermic medicine both at home and abroad has, but has shortcomings such as drug price height, medical expense is big, effect is not ideal enough.
Summary of the invention:
The objective of the invention is at present weak point on the treatment vitiligo, and a kind of new raw material of Chinese medicine combination, leukodermic medicine for external application of treatment and preparation method evident in efficacy are provided.
Technical scheme of the present invention is achieved in that
The leukodermic medicine for external application of a kind of treatment, its medicine is to be made by the raw material of following weight parts: Fructus Atriplicis Sibiricae flower, each 10 gram of the Radix Aucklandiae, sulfur, each 15 gram of Camphora, Lithargyrum's 30 grams, Mylabris 6 grams, Calomelas 12 grams, 1000 milliliters of rice vinegars.
The leukodermic medicine for external application of a kind of treatment, the preparation method of its medicine is: 7 flavors before the above-mentioned raw material of Chinese medicine are fried with brown rice respectively, and remove brown rice, be ground into fine powder, cross 120 mesh sieves, mix homogeneously adds rice vinegar, mixes, go into pot, decoct 10 minutes, the cooling, medicine for external application.
The leukodermic medicine for external application of a kind of treatment, its Therapeutic Principle is the liver and the kidney tonifying, sterilization detoxifcation.On composition of raw materials, follow the property of medicine through belonging to, lay particular stress on the liver and the kidney tonifying, take into account whole machine balancing, the sterilization detoxifcation of stopping over.The Fructus Atriplicis Sibiricae flower has the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs effect in the medicine, the Radix Aucklandiae has warming middle-JIAO for easing the stomach, circulation of qi promoting effect, sulfur has the killing pests and suppressing bacteria effect, Camphora has parasite killing, sensible effect, the Lithargyrum has parasite killing, detumescence, antisepsis, Mylabris has the effect of counteracting toxic substances removing blood stasis, and Calomelas has counteracting toxic substances, diuretic effect, and rice vinegar has the detoxicating, killing bacteria effect.Above-mentioned Chinese medicine is through dialectical compatibility, complements each other using, and medicine is directly invested focus, thereby given play to the liver and the kidney tonifying, sterilization antidotal effect effectively, to reach the purpose of curing vitiligo.
The present invention has following characteristics: fill a prescription novel, with low cost, easy to prepare, effect is remarkable.
Using method:
Consumption: every day 2 times.Method: earlier with 70% alcohol disinfecting affected part, dip in medicine with absorbent liquor ball then and be applied to the affected part before the medication, each use is coated with repeatedly puts 3-5 time on the skin.
The taboo item:
1, fried sticky, the cold solid food hard, nondigestible and excitatory of taboo edible oil during the medication.
2, forbid taking orally.
Clinical therapeutic efficacy:
Criterion of therapeutical effect: the curative effect of the leukodermic medicine for external application treatment of a kind of treatment vitiligo judges whether mainly be dependent on the vitiligo symptom disappears.Medication 30 days was 1 course of treatment.Concrete curative effect is divided following three grades: cure---and the vitiligo symptom all disappears; Taking a turn for the better---the vitiligo symptom obviously alleviates; Invalid---after medication 1 course of treatment, the vitiligo symptom has no to disappear.
Effect: with Drug therapy patients with vitiligo 17 examples of the present invention, treat 1 course of treatment, wherein cure 13 examples, 4 examples that take a turn for the better, cure rate is 76%, effective percentage is 100%.
Model case:
Lee, the woman 37 years old, is engaged in agriculture.Go to a doctor in March, 2004.Patient's readme was suffered from vitiligo 4 years, once used multiple medicine, did not take effect.Adopt medicine for external application of the present invention, continuous use 30 days, vitiligo disappears.

Claims (1)

1. the leukodermic medicine for external application of treatment is characterized in that this medicine made by following raw material: Fructus Atriplicis Sibiricae flower, each 10 gram of the Radix Aucklandiae, sulfur, each 15 gram of Camphora, Lithargyrum's 30 grams, Mylabris 6 grams, Calomelas 12 grams, 1000 milliliters of rice vinegars.
CN2007103055576A 2007-12-19 2007-12-19 External medicine for vitligo Expired - Fee Related CN101204410B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007103055576A CN101204410B (en) 2007-12-19 2007-12-19 External medicine for vitligo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007103055576A CN101204410B (en) 2007-12-19 2007-12-19 External medicine for vitligo

Publications (2)

Publication Number Publication Date
CN101204410A CN101204410A (en) 2008-06-25
CN101204410B true CN101204410B (en) 2011-09-21

Family

ID=39565038

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007103055576A Expired - Fee Related CN101204410B (en) 2007-12-19 2007-12-19 External medicine for vitligo

Country Status (1)

Country Link
CN (1) CN101204410B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547321A (en) * 2014-12-18 2015-04-29 王旭 Traditional Chinese medicine composition for treating leucoderma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315183A (en) * 2000-03-30 2001-10-03 陈江辉 Tincture for treating leukoderma and its preparing process
CN1483469A (en) * 2003-07-21 2004-03-24 马柏林 Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315183A (en) * 2000-03-30 2001-10-03 陈江辉 Tincture for treating leukoderma and its preparing process
CN1483469A (en) * 2003-07-21 2004-03-24 马柏林 Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof

Also Published As

Publication number Publication date
CN101204410A (en) 2008-06-25

Similar Documents

Publication Publication Date Title
CN101194986A (en) Exterior washing medicament for treating zoster
CN106377602A (en) Dendrobium officinale composite disinfection powder, and preparation method and application method thereof
CN102920941A (en) Plaster for treating red and swollen sore and anonymous gall and preparation method of plaster
CN101204410B (en) External medicine for vitligo
CN101313959B (en) Plaster medicament for treating scabies
CN101199830B (en) Heat-transfer dose medicament for treating migraine
CN101313962B (en) Decoction medicament for treating impetigo
CN101332242B (en) Decoction for treating hemorrhoidal hemorrhage
CN101288708A (en) Chinese medicinal preparation for treating ophthalmic vertigo
CN101288689A (en) Orally-taken traditional Chinese medicines for treating light headedness
CN101199688B (en) Tincture dose medicament for treating part frozen
CN101194929A (en) Powder medicament for treating decubitus
CN101204414A (en) Pasty medicine for treating asthma
CN101306148B (en) Traditional Chinese medicine orally taken for treating intractable psoriasis
CN101199732A (en) Mud plaster medicament for treating corn
CN101204399B (en) External medicine for tinea pedis
CN101306114B (en) Chinese traditional medicine orally taken for treating periodontitis
CN101185697B (en) Ointment medicine for treating anal fissure
CN101332245B (en) Decoction for treating influenza
CN101199582B (en) Paste medicament for treating acne
CN101194977A (en) Plaster medicament for treating closed traumatic injury
CN101199610B (en) Paste medicament for treating acute appendicitis
CN101306165B (en) Decoction for treating lung impairment and cough
CN101194973B (en) Infusion medicament for treating impetigo
CN101204452B (en) Tincture medicine for verruca plana

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110921

Termination date: 20111219